U.S. markets closed
  • S&P Futures

    4,571.75
    +0.50 (+0.01%)
     
  • Dow Futures

    35,299.00
    +40.00 (+0.11%)
     
  • Nasdaq Futures

    15,193.00
    -13.00 (-0.09%)
     
  • Russell 2000 Futures

    2,093.80
    +1.70 (+0.08%)
     
  • Crude Oil

    87.01
    +1.58 (+1.85%)
     
  • Gold

    1,812.40
    0.00 (0.00%)
     
  • Silver

    23.50
    +0.00 (+0.01%)
     
  • EUR/USD

    1.1329
    -0.0001 (-0.01%)
     
  • 10-Yr Bond

    1.8650
    +0.0930 (+5.25%)
     
  • Vix

    22.79
    +3.60 (+18.76%)
     
  • GBP/USD

    1.3603
    +0.0005 (+0.04%)
     
  • USD/JPY

    114.6700
    +0.0850 (+0.07%)
     
  • BTC-USD

    42,434.91
    +201.88 (+0.48%)
     
  • CMC Crypto 200

    1,011.58
    +2.19 (+0.22%)
     
  • FTSE 100

    7,563.55
    -47.68 (-0.63%)
     
  • Nikkei 225

    27,729.28
    -527.97 (-1.87%)
     

Nanosonics' (ASX:NAN) Returns On Capital Are Heading Higher

  • Oops!
    Something went wrong.
    Please try again later.
·3 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

What are the early trends we should look for to identify a stock that could multiply in value over the long term? Amongst other things, we'll want to see two things; firstly, a growing return on capital employed (ROCE) and secondly, an expansion in the company's amount of capital employed. If you see this, it typically means it's a company with a great business model and plenty of profitable reinvestment opportunities. With that in mind, we've noticed some promising trends at Nanosonics (ASX:NAN) so let's look a bit deeper.

Return On Capital Employed (ROCE): What is it?

For those who don't know, ROCE is a measure of a company's yearly pre-tax profit (its return), relative to the capital employed in the business. Analysts use this formula to calculate it for Nanosonics:

Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities)

0.069 = AU$9.8m ÷ (AU$162m - AU$20m) (Based on the trailing twelve months to June 2021).

So, Nanosonics has an ROCE of 6.9%. Ultimately, that's a low return and it under-performs the Medical Equipment industry average of 15%.

View our latest analysis for Nanosonics

roce
roce

Above you can see how the current ROCE for Nanosonics compares to its prior returns on capital, but there's only so much you can tell from the past. If you're interested, you can view the analysts predictions in our free report on analyst forecasts for the company.

How Are Returns Trending?

Nanosonics has recently broken into profitability so their prior investments seem to be paying off. Shareholders would no doubt be pleased with this because the business was loss-making five years ago but is is now generating 6.9% on its capital. Not only that, but the company is utilizing 140% more capital than before, but that's to be expected from a company trying to break into profitability. This can tell us that the company has plenty of reinvestment opportunities that are able to generate higher returns.

What We Can Learn From Nanosonics' ROCE

In summary, it's great to see that Nanosonics has managed to break into profitability and is continuing to reinvest in its business. And with a respectable 85% awarded to those who held the stock over the last five years, you could argue that these developments are starting to get the attention they deserve. With that being said, we still think the promising fundamentals mean the company deserves some further due diligence.

Before jumping to any conclusions though, we need to know what value we're getting for the current share price. That's where you can check out our FREE intrinsic value estimation that compares the share price and estimated value.

While Nanosonics isn't earning the highest return, check out this free list of companies that are earning high returns on equity with solid balance sheets.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.